Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.

Dang V, Jamieson FB, Wilson S, Rawte P, Crowcroft NS, Johnson K, Tsang RS, Deeks SL.

BMC Infect Dis. 2012 Aug 29;12:202. doi: 10.1186/1471-2334-12-202.

2.

Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.

Wormsbecker AE, Wong K, Jamieson FB, Crowcroft NS, Deeks SL.

Vaccine. 2015 Oct 13;33(42):5678-83. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.

3.

Epidemiology of invasive meningococcal disease in Austria 2010.

Steindl G, Liu YL, Schmid D, Orendi U, Kormann-Klement A, Heuberger S.

Wien Klin Wochenschr. 2011 Oct;123 Suppl 1:10-4. doi: 10.1007/s00508-011-0058-0. Epub 2011 Sep 26.

PMID:
21935643
4.

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.

Kinlin LM, Jamieson F, Brown EM, Brown S, Rawte P, Dolman S, Drews SJ, Fisman DN.

Vaccine. 2009 Mar 10;27(11):1735-40. doi: 10.1016/j.vaccine.2009.01.026. Epub 2009 Jan 30.

PMID:
19186206
5.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
6.

Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014.

Stefanelli P, Fazio C, Neri A, Boros S, Renna G, Pompa MG; National Surveillance System Collaborative Centers.

Vaccine. 2015 Jul 17;33(31):3678-81. doi: 10.1016/j.vaccine.2015.06.032. Epub 2015 Jun 16.

PMID:
26087297
7.

[Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].

Křížová P, Vacková Z, Musílek M, Kozáková J.

Epidemiol Mikrobiol Imunol. 2013 Dec;62(4):138-47. Czech.

PMID:
24467175
8.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
9.

Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007.

Muscat M, Spiteri G, Calleja N, Haider J, Gray SJ, Melillo JM, Mamo J, Cuschieri P.

J Med Microbiol. 2009 Nov;58(Pt 11):1492-8. doi: 10.1099/jmm.0.011312-0. Epub 2009 Jul 9.

PMID:
19589903
10.

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.

Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209.

PMID:
20001736
11.

The disease burden of invasive meningococcal serogroup B disease in Canada.

Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R; Members of Canadian Immunization Monitoring Program, Active (IMPACT).

Pediatr Infect Dis J. 2013 Jan;32(1):e20-5. doi: 10.1097/INF.0b013e3182706b89.

PMID:
22926207
12.

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction.

Martinelli D, Fortunato F, Cappelli MG, Cozza V, Chironna M, Prato R.

J Immunol Res. 2015;2015:710656. doi: 10.1155/2015/710656. Epub 2015 Aug 17.

13.

Vaccine strategies of meningococcal disease: results of a 10-year population-based study.

Biebl A, Hartmann G, Bernhard C, Bechter E, Luckner-Hornischer A, Frühwirth M, Heuberger S, Offner F, Barbieri V, Simma B.

Eur J Pediatr. 2005 Dec;164(12):735-40. Epub 2005 Aug 27.

PMID:
16133244
14.

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Racloz VN, Luiz SJ.

BMC Infect Dis. 2010 Jun 17;10:175. doi: 10.1186/1471-2334-10-175. Review.

15.

Epidemiology of infant meningococcal disease in the United States, 2006-2012.

MacNeil JR, Bennett N, Farley MM, Harrison LH, Lynfield R, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Pondo T, Mayer LW, Clark TA, Cohn AC.

Pediatrics. 2015 Feb;135(2):e305-11. doi: 10.1542/peds.2014-2035. Epub 2015 Jan 12.

16.

Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.

Poland GA.

Clin Infect Dis. 2010 Mar 1;50 Suppl 2:S45-53. doi: 10.1086/648964. Review.

PMID:
20144016
17.

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.

Hill DM, Lucidarme J, Gray SJ, Newbold LS, Ure R, Brehony C, Harrison OB, Bray JE, Jolley KA, Bratcher HB, Parkhill J, Tang CM, Borrow R, Maiden MC.

Lancet Infect Dis. 2015 Dec;15(12):1420-8. doi: 10.1016/S1473-3099(15)00267-4. Epub 2015 Oct 27. Erratum in: Lancet Infect Dis. 2016 Jan;16(1):16. Lancet Infect Dis. 2016 Jan;16(1):16.

18.

Meningococcal disease and vaccination in North America.

Pollard AJ, Scheifele D.

J Paediatr Child Health. 2001 Oct;37(5):S20-7.

PMID:
11885732
19.

Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Siu T, Tang W, Dawar M, Patrick DM.

Can J Public Health. 2008 Sep-Oct;99(5):380-2.

PMID:
19009920
20.

[Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].

Goicoechea Sáez M, Fullana Montoro AM, Momparler Carrasco P, Redondo Gallego MJ, Brines Solanes J, Bueno Cañigral FJ.

Rev Esp Salud Publica. 2003 Jan-Feb;77(1):125-42. Spanish.

Supplemental Content

Support Center